News

The longer-acting version of human growth hormone, hGH-CTP, is being developed to treat growth hormone deficiency. PROLOR CEO Dr. Abraham Havron said, "By reducing the dosing frequency to

A violation of the Pharmaceutical Affairs Act coupled with the voluntary recall of ALINAMIN-F5 Injection, Lot H123, was mentioned in the order. Nihon Pharmaceutical, the contract manufacturer and

The collaboration, which is scheduled for two years, will focus on integrating the capabilities and technologies of both the companies to increase the value of specific projects by

According to the strategic collaboration, Mylan gains rights to develop and market Biocon’s Glargine, Lispro and Aspart. Glargine, Lispro and Aspart are the generic equivalents to Sanofi’s Lantus,

K&L, which provides end-to-end services for all types of clinical studies, said it is planning to expand its capabilities in the US, Asia and the Pacific region, especially

Under the agreement, Boehringer will implement ChemAxon’s chemistry software platform for use in multiple applications across research and development, supporting in-house activities and work with external collaboration partners.

Prior to joining the company, Adams served at Auxilium Pharmaceuticals as chief executive officer and president and at Neurologix as chairman and chief executive officer. Adams also worked

According to the deal, Cellmid will receive initial fee besides additional payment if Fujikura decides on exercising its license option. Upon any future sales of midkine diagnostic products

The patent entitled, ‘Abuse-Deterrent Drug Formulation’, covers Oxycodone DETERx (COL-003) product which utilizes the company’s proprietary DETERx drug delivery technology. Currently in the final stage of clinical development,